secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001493152-24-039111
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics presents at Injectables Summit with Enable on SER-252 for Parkinson's
--------------------------------------------------------------------------------

- Serina's CDO Randall Moreadith presents at 14th Annual Injectables Summit in Boston on October 2, 2024.
- Joint presentation with Enable Injections' CCO Matthew Huddleston focuses on SER-252 for advanced Parkinson's disease.
- Partnership combines Serina's SER-252 with Enable's enFuse wearable drug delivery platform.
- No financial results, guidance, or other material corporate updates were provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224039111/0001493152-24-039111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224039111/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-039111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer